Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Ishikawa

Showing results (281-290 of 404) with videos related to

Pageof 41
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 15, 2010
Dose-volume histogram parameters and clinical factors associated with pleural effusion after chemoradiotherapy in esophageal cancer patientsKatsuyuki Shirai, Yoshio Tamaki, Yoshizumi Kitamoto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2014
Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapyMasashi Mizumoto, Yoshiko Oshiro, Toshiyuki Okumura, et al.
Japanese Journal of Clinical Oncology|July 7, 2020
National survey of radiation oncologists' practice patterns regarding hormone-naïve prostate cancer with bone metastasesKatsumasa Nakamura, Hitoshi Ishikawa, Tetsuo Akimoto, et al.
Japanese Journal of Radiology|April 17, 2015
Prediction error and required internal margin provided for irregular respiratory movements: a phantom studyNobuyoshi Fukumitsu, Haruko Numajiri, Kayoko Ohnishi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 29, 2023
Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: A Japanese national registry study (J-CROS-LUNG)Nobuteru Kubo, Hiroaki Suefuji, Mio Nakajima, et al.
Cancers|February 10, 2024
Safety and Efficacy of Single-Fraction Carbon-Ion Radiotherapy for Early-Stage Lung Cancer with Interstitial PneumoniaShuri Aoki, Hitoshi Ishikawa, Mio Nakajima, et al.
Radiological Physics and Technology|May 1, 2024
Inter-fractional error and intra-fractional motion of prostate and dosimetry comparisons of patient position registrations with versus without fiducial markers during treatment with carbon-ion radiotherapyYuma Iwai, Shinichiro Mori, Hitoshi Ishikawa, et al.
BMC Cancer|February 1, 2020
Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study "GUNMA0702"Hidemasa Kawamura, Nobuteru Kubo, Hiro Sato, et al.
International Journal of Radiation Oncology, Biology, Physics|December 5, 2006
Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysisNaoki Hirasawa, Hiroshi Tsuji, Hitoshi Ishikawa, et al.
Cancers|August 26, 2022
Safety and Efficacy of Carbon-Ion Radiotherapy for Elderly Patients with High-Risk Prostate CancerYuichi Hiroshima, Hitoshi Ishikawa, Yuma Iwai, et al.
Pageof 41

Showing results (281-290 of 404) with videos related to

Sort By:
Pageof 41
International Journal of Radiation Oncology, Biology, Physics|June 15, 2010
Dose-volume histogram parameters and clinical factors associated with pleural effusion after chemoradiotherapy in esophageal cancer patientsKatsuyuki Shirai, Yoshio Tamaki, Yoshizumi Kitamoto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2014
Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapyMasashi Mizumoto, Yoshiko Oshiro, Toshiyuki Okumura, et al.
Japanese Journal of Clinical Oncology|July 7, 2020
National survey of radiation oncologists' practice patterns regarding hormone-naïve prostate cancer with bone metastasesKatsumasa Nakamura, Hitoshi Ishikawa, Tetsuo Akimoto, et al.
Japanese Journal of Radiology|April 17, 2015
Prediction error and required internal margin provided for irregular respiratory movements: a phantom studyNobuyoshi Fukumitsu, Haruko Numajiri, Kayoko Ohnishi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 29, 2023
Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: A Japanese national registry study (J-CROS-LUNG)Nobuteru Kubo, Hiroaki Suefuji, Mio Nakajima, et al.
Cancers|February 10, 2024
Safety and Efficacy of Single-Fraction Carbon-Ion Radiotherapy for Early-Stage Lung Cancer with Interstitial PneumoniaShuri Aoki, Hitoshi Ishikawa, Mio Nakajima, et al.
Radiological Physics and Technology|May 1, 2024
Inter-fractional error and intra-fractional motion of prostate and dosimetry comparisons of patient position registrations with versus without fiducial markers during treatment with carbon-ion radiotherapyYuma Iwai, Shinichiro Mori, Hitoshi Ishikawa, et al.
BMC Cancer|February 1, 2020
Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study "GUNMA0702"Hidemasa Kawamura, Nobuteru Kubo, Hiro Sato, et al.
International Journal of Radiation Oncology, Biology, Physics|December 5, 2006
Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysisNaoki Hirasawa, Hiroshi Tsuji, Hitoshi Ishikawa, et al.
Cancers|August 26, 2022
Safety and Efficacy of Carbon-Ion Radiotherapy for Elderly Patients with High-Risk Prostate CancerYuichi Hiroshima, Hitoshi Ishikawa, Yuma Iwai, et al.
Pageof 41